Our Pricing

Buy Mounjaro Jab Online - UK Prescription Service

When you buy Mounjaro jab online UK through Cured Pharmacy, you receive genuine tirzepatide KwikPens from £135.00 dispensed by our UK-registered clinical team after a free online consultation. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) ensures every prescription meets MHRA standards, with transparent pricing shown before your assessment begins.

How Mounjaro Tirzepatide Works for Weight Loss

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for chronic weight management in the UK [1]. Unlike single-pathway treatments, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, creating a synergistic effect that reduces appetite, slows gastric emptying, and improves insulin sensitivity.

In the SURMOUNT-1 trial involving 2,539 adults with obesity, participants receiving the 15mg maintenance dose achieved an average body weight reduction of 22.5% over 72 weeks [1]. This represents the highest average weight loss recorded in any major obesity trial to date, surpassing results from semaglutide-based treatments in head-to-head comparisons [2].

The dual-receptor mechanism means Mounjaro may offer advantages for patients who have not responded adequately to single GLP-1 treatments. Your UK prescriber will assess your medical history, current BMI, and any contraindications during your online consultation to determine if tirzepatide is suitable for your weight management goals.

Mounjaro Dosing Schedule and What to Expect

Mounjaro is administered as a once-weekly subcutaneous injection using a pre-filled KwikPen device. The treatment follows a structured dose escalation schedule designed to minimise gastrointestinal side effects whilst building therapeutic efficacy [3].

Most patients begin with 2.5mg weekly for four weeks, then increase to 5mg weekly. Your prescriber may continue escalating the dose every four weeks (to 7.5mg, 10mg, 12.5mg, or 15mg) based on your weight loss response and tolerability. Clinical trials demonstrate that gradual titration significantly reduces the incidence of nausea and vomiting compared to starting at higher doses [3].

Weight loss typically becomes noticeable within the first 4-8 weeks, with peak effects observed after 16-20 weeks at your maintenance dose. In SURMOUNT-1, over 50% of participants achieved at least 20% body weight reduction by week 72, and 89% achieved at least 5% reduction [1]. Results vary between individuals and depend on adherence to the prescribed regimen alongside dietary and lifestyle modifications.

Injection Technique and Storage

The Mounjaro KwikPen is designed for self-administration into the abdomen, thigh, or upper arm. Each pen contains four weekly doses and should be stored in the refrigerator between 2°C and 8°C until first use. Once in use, the pen may be kept at room temperature (up to 30°C) for up to 21 days. Your pharmacist will provide detailed administration instructions with your first prescription, and video guides are available on the manufacturer's website.

Buy Mounjaro Jab Online UK: The Cured Pharmacy Process

Our online prescription service is designed to make accessing Mounjaro straightforward whilst maintaining the highest clinical standards. The process begins with a free online consultation that takes under three minutes to complete. You'll answer questions about your current weight, height, medical history, existing medications, and any previous weight loss treatments.

A UK-registered prescriber from our clinical team reviews your assessment within hours. If Mounjaro is deemed clinically appropriate and safe for you, they will issue a prescription electronically to our GPhC-registered pharmacy (9012511). We only dispense genuine UK-licensed Mounjaro manufactured by Eli Lilly, sourced through authorised UK wholesalers.

Your medication is dispatched in 100% discreet packaging with next-day delivery options available across the UK. Every order includes patient information leaflets, injection technique guides, and access to our clinical support team if you have questions during your treatment. Pricing is transparent from the outset — you'll see the exact cost before submitting your consultation, with no hidden fees.

Who Can Be Prescribed Mounjaro?

NICE guidance recommends tirzepatide for adults with a BMI of 30 kg/m² or above, or 27 kg/m² with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [4]. Your prescriber will assess whether you meet these criteria and evaluate any contraindications, including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, or pregnancy. Mounjaro is not licensed for individuals under 18 or over 75 years of age.

Mounjaro vs Wegovy vs Saxenda: Comparing UK Weight Loss Injections

All three medications are injectable treatments licensed by the MHRA for chronic weight management, but they differ in mechanism, dosing frequency, and clinical outcomes. Understanding these differences helps you and your prescriber choose the most appropriate option for your circumstances.

Mounjaro (tirzepatide) is the only dual GIP/GLP-1 receptor agonist, whilst Wegovy (semaglutide) and Saxenda (liraglutide) are single GLP-1 receptor agonists. Head-to-head trial data from SURPASS-2 showed that tirzepatide 15mg produced significantly greater weight loss than semaglutide 1mg over 40 weeks [2]. Saxenda requires daily injections, whereas both Mounjaro and Wegovy are administered once weekly, which many patients find more convenient.

In terms of side effect profiles, all three medications can cause gastrointestinal symptoms such as nausea, diarrhoea, and constipation, particularly during dose escalation. These effects are generally mild to moderate and diminish over time [1][2][5]. Your prescriber will consider your tolerance for injection frequency, previous treatment responses, and any existing medical conditions when recommending a specific medication.

Common Side Effects and How to Manage Them

The most frequently reported side effects of Mounjaro are gastrointestinal in nature. In clinical trials, nausea occurred in approximately 25-30% of participants, diarrhoea in 20-25%, and vomiting in 10-15% [1]. These symptoms are typically most pronounced during the first few weeks after starting treatment or increasing the dose, and tend to resolve as your body adjusts to the medication.

To minimise gastrointestinal discomfort, eat smaller, more frequent meals rather than large portions, avoid high-fat and spicy foods, and stay well-hydrated throughout the day. Taking your injection on the same day each week and at the same time can help maintain stable drug levels and reduce symptom variability. If nausea persists or becomes severe, contact your prescriber — they may recommend remaining at your current dose for an additional four weeks before escalating further.

Rare but serious side effects include pancreatitis (severe abdominal pain radiating to the back), gallbladder disease, and hypoglycaemia if used alongside insulin or sulfonylureas. Seek immediate medical attention if you experience persistent severe abdominal pain, yellowing of the skin or eyes, or symptoms of an allergic reaction such as difficulty breathing or facial swelling. Your prescriber will monitor your progress through follow-up consultations to ensure the treatment remains safe and effective.

When to Contact Your Prescriber

You should reach out to your clinical team if you experience side effects that do not improve after two weeks, if you are unable to tolerate your current dose, or if you have concerns about your weight loss progress. Our pharmacists are available on (+44) 116 4646009 during business hours, and urgent clinical queries are triaged the same day. Never adjust your dose or stop treatment without consulting your prescriber, as abrupt discontinuation may affect your weight management outcomes.

Supporting Your Weight Loss Journey with Lifestyle Changes

Whilst Mounjaro is highly effective at reducing body weight, clinical trials consistently demonstrate that the best outcomes occur when medication is combined with structured dietary modifications and increased physical activity [1][4]. NICE recommends that all patients prescribed weight loss medications participate in a comprehensive weight management programme that addresses nutrition, exercise, and behavioural factors.

A balanced, calorie-controlled diet rich in vegetables, lean proteins, and whole grains supports the appetite-suppressing effects of tirzepatide. Because Mounjaro slows gastric emptying, you may find that you feel full more quickly — listen to these satiety signals and avoid eating beyond comfortable fullness. Aim for at least 150 minutes of moderate-intensity aerobic activity per week, such as brisk walking, cycling, or swimming, alongside muscle-strengthening exercises twice weekly.

Behavioural strategies such as keeping a food diary, identifying emotional eating triggers, and setting realistic short-term goals can enhance long-term success. Many patients find that working with a registered dietitian or joining a structured weight management programme provides additional accountability and support. At Cured Pharmacy, our clinical team can signpost you to NHS and charity resources that complement your pharmacological treatment.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., Stefanski, A., & SURMOUNT-1 Investigators. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–218. https://doi.org/10.1056/NEJMoa2206038
2. Frías, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., Liu, B., Cui, X., Brown, K. D., SURPASS-2 Investigators. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519
3. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. MHRA. Retrieved from https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
4. National Institute for Health and Care Excellence. (2023). Tirzepatide for treating obesity [TA1027]. NICE. Retrieved from https://www.nice.org.uk/guidance/ta1027
5. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., Kushner, R. F., & STEP 1 Study Group. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment alongside dietary and lifestyle modifications.